DianeBodurkaMD
Obstetrics & Gynecology • Houston, TXGynecologic Oncology
Vice President, Chief Education & Training Officer Professor of Gynecologic Oncology, UT MD Anderson Cancer Center
Dr. Bodurka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1994 - 1996
University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 1990 - 1994
Georgetown University School of MedicineClass of 1990
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 1994 - 2025
OK State Medical License 2020 - 2021
AL State Medical License 1992 - 1994- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2010-2013
- Join now to see all
Clinical Trials
- PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2002 Jul 01
- Elizabeth Registry for Low Grade Ovarian Cancer Start of enrollment: 2003 Sep 01
- Chemotherapy-Related Toxicities In Ovarian Cancer Patients Start of enrollment: 2001 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Improving handoff with the implementation of I-PASS at a tertiary oncology hospital.Maria C Franco Vega, Mohamed Ait Aiss, Maura Smith, Marina George, Lakeisha Day
BMJ Open Quality. 2023-10-01 - 12 citationsTransfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the Eur...Lauren Shore Prescott, Ignace Vergote, Charlotte C Sun, Diane C Bodurka, Robert L Coleman
International Journal of Gynecological Cancer. 2023-01-03 - 2 citationsAn Integrated Approach to Selecting a Prepared Medical Decision-MakerDonna S. Zhukovsky, Ali S Haider, Janet L. Williams, Syed Naqvi, Neeraj Joshi
Journal of Pain and Symptom Management. 2021-06-01
Journal Articles
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerShannon N Westin, Lois M Ramondetta, Kathleen M Schmeler, Pamela T Soliman, Nicole D Fleming, Jennifer K Burzawa, Alpa M Nick, Andrea M Milbourne, Diane C Bodurka, Rob..., American Journal of Obstetrics and Gynecology
Authored Content
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
Press Mentions
Howard University President Dr. Wayne A. I. Frederick Selected by MD Anderson Cancer Center for 2019 Distinguished Alumnus AwardMay 3rd, 2019
Why My Cervical Cancer Diagnosis Led Me to MD Anderson for a Second OpinionOctober 13th, 2017
Best of the Best in Care: Meet Houston's Top Doctors 2016October 21st, 2016
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
